期刊文献+

伴有髓系分化抗原表达的神经母细胞瘤骨髓转移1例并文献复习 被引量:1

A case report of neuroblastoma bone marrow metastasis with myeloid antigen expression and review of literature
下载PDF
导出
摘要 目的:报道伴有髓系抗原表达的神经母细胞瘤骨髓转移患儿1例,并进行文献复习。方法:取患者骨髓液进行细胞形态学分析及流式细胞术检测细胞分化抗原。结果:该患者骨髓形态学考虑为神经母细胞瘤髓内转移,经流式细胞术分析异常细胞同时表达髓系分化抗原CD13、CD15和CD11b,结合影像学检查确诊为神经母细胞瘤(Ⅳ期)。结论:复习相关文献并结合本例报道发现神经母细胞瘤细胞和造血细胞拥有一些相同的抗原决定簇,可伴有髓系及淋巴系分化抗原的表达,但其在神经母细胞瘤的分化程度、临床分期、疗效及预后判断上的作用尚需进一步研究。 Objective:To report one case of neuroblastoma bone marrow metastasis with myeloid antigen expression and review literature.Methods:Bone marrow sample was collected to perform morphological and cytochemical examination,and analyze cluster of differentiation by flow cytometry.Results:According to morphological and cytochemical test,the child was considered as neuroblastoma bone marrow metastasis,flow cytometry showed abnormal cells both expressed myeloid antigen CD13,CD15 and CD11b,combined with the examination of imageology,the child was diagnosed as neuroblastoma(Ⅳ stage) at last.Conclusion:Neuroblastoma cells and hematopoietic cells had the same antigen determinant,the cells can express both myeloid and lymphoid antigen.However,its contribution to the differentiation,clinical stage,curative effect and prognosis of neuroblastoma would be needed for more investigation.
出处 《现代肿瘤医学》 CAS 2010年第4期771-773,共3页 Journal of Modern Oncology
基金 国家自然科学基金资助项目(编号:30950021)
关键词 神经母细胞瘤 骨髓转移 流式细胞术 髓系分化抗原 neuroblastoma bone marrow metastasis flow cytometry myeloid antigen
  • 相关文献

参考文献11

  • 1Chen S,Caragine T,Cheung NK,et al.Surface antigen expression and complement susceptibility of differentiated neuroblastoma clones[J].Am J Pathol,2000,156:1085-1091.
  • 2杨世隆,汤永民,沈红强,钱柏芹,宋华,石淑文,徐卫群,宁铂涛,陈英虎.神经母细胞瘤细胞系血细胞分化抗原的表达[J].中华儿科杂志,2004,42(3):215-216. 被引量:2
  • 3Carl-McGrath S,Lendeckel U,Ebert M,et al.The ectopeptidases CD10,CD13,CD26 and CD143 are upregulated in gastric cancer[J].Int J Oncol,2004,25(5):1223-1232.
  • 4Liu F,Qi HL,Chen HL.Regulation of differentiation and proliferation-inducers on Lewis antigens,alpha-fucosyltransferase and metastatic potential in hepatocarcinoma cells[J].Br J Cancer,2001,84(11):1556-1563.
  • 5李梅,杨胜,陈玉梅,于明华,于成龙,蔡文宇,崔雯,张婉红,竺晓凡.以血液学临床指标异常为首发表现的神经母细胞瘤骨髓转移18例[J].中华血液学杂志,2007,28(1):52-53. 被引量:3
  • 6Sjogren F,Ljunghusen O,Baas A,et al.Expression and function of β2 intergrin CD11B/CD18 on leukocytes from patients with psoriasis[J].Acta Derm Venereol,1999,79(2):105-110.
  • 7Sugimoto T,Tatsumi E,Kemshead JT,et al.Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies[J].J Natl Cancer Inst,1984,73:51-73.
  • 8Komada Y,Azuma E,Kamiya H,et al.Phenotypic profile of human neuroblastoma cell lines:association with morphological characteristics[J].Br J Cancer,1986,54:711-715.
  • 9Ebener U,Wehner S,Cinatl J,et al.Expression of markers shared between human haematopoietic cells and neuroblastoma cells[J].Anticancer Res,1990,10:887-890.
  • 10Nagai J,Ishida Y,Koga N,et al.A new sensitive and specific combination of CD81 / CD56 /CD45 monoclonal antibodies for detecting circulating neuroblastoma cells in peripheral blood using flow cytometry[J].J Pediatr Hematol Oncol,2000,22 (1):20 -26.

二级参考文献18

  • 1余亚雄.小儿肿瘤学[M].上海:上海人民出版社,1997.3.
  • 2Faulkner LB, Tintori V, Tamburini A, et al. High-senstivity immunocytologic analysis of neuroblastoma cells in paired blood and marrow samples. J Hematother , 1998, 7(4) : 361-366.
  • 3Nagai J, Ishida Y, Koga N, et al. A new sensitive and specific combination of CD81/CD56/CD45 monoclonal antibodies for detecting circulating neuroblastoma cells in peripheral blood using flow cytometry .J Pediatr Hematol Oncol,2000,22(1) :20-26.
  • 4Bernard F, Aerts I, Margueritte G, et al. Micrometastases in pediatric oncology.Bull Cancer, 2001,88(6):577-580.
  • 5Wu ZL, Schwartz E,Seeger R, et al. Expression of GD2 ganglioside by untreated primary human neuroblastomas.Cancer Res, 1986,46(1) :440-443.
  • 6Sariola H, Terava H, Rapola,et al. Cell-surface ganglioside GD2 in the immunohistochemical detection and differential diagnosis of neuroblastoma. Am J Clin Pathol, 1991,96(2) :248-252.
  • 7Reynolds CP, Seeger RC. Detection of minimal residual disease in bone marrow during or after therapy as a prognostic marker for high-risk neuroblastoma. Am J Pediatr Hematol Oncol, 2001,23(3):150-152.
  • 8Seeger RC, Reynolds CP, Galhgo R, et al. Quantitative tumor cell content of bone marrow and blood as predictor of outcome in stage IV neuroblastoma:A children's cancer group study .J Clin Oncol, 2000,2000,18(24) :4067-4076.
  • 9胡亚美 江载芳 等 主编.诸福棠实用儿科学(第7版)[M].北京:人民卫生出版社,2002.458~461.
  • 10Sawada T.Past and future of neuroblastoma screening in Japan.Am J Pediatr Hematol Oncol,1992,14:320-326.

共引文献3

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部